Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations

British Journal of Pharmacology

Volumn 160, Issue 2, 2010, Pages 283-291

  Ludolph, Andrea G ^a   Udvardi, Patrick T ^a   Schaz, Ulrike ^a   Henes, Carolin ^a   Adolph, Oliver ^a   Weigt, Henry U ^a   Fegert, Joerg M ^a   Boeckers, Tobias M ^a   Föhr, Karl J ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

ADHD; Atomoxetine; Glutamate metabolism; NMDA receptor; Transporter inhibitor; Whole cell patch clamp

Indexed keywords

ATOMOXETINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN REGION; CELL STRAIN HEK293; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; HETEROLOGOUS EXPRESSION; HIPPOCAMPUS; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MEMBRANE CURRENT; NEUROTRANSMISSION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR OCCUPANCY;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CELL LINE; CELLS, CULTURED; CEREBRAL CORTEX; HIPPOCAMPUS; HUMANS; NEURONS; PATCH-CLAMP TECHNIQUES; PROPYLAMINES; RATS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 77951695580     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00707.x     Document Type: Article

References (37)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 S209. (Pubitemid 351415518)
2. Bertolino M, Vicini S (1988). Voltage-dependent block by strychnine of N-Methyl-D-Aspartic-acid-activated cationic channels in rat cortical neurons in culture. Mol Pharmacol 34 : 98 103.
3. Biederman J, Faraone SV (2005). Attention-deficit hyperactivity disorder. Lancet 366 : 237 248. (Pubitemid 40981053)
4. Carrey N, MacMaster FP, Sparkes SJ, Khan SC, Kusumakar V (2002). Glutamatergic changes with treatment in attention deficit hyperactivity disorder: a preliminary case series. J Child Adolesc Psychopharmacol 12 : 331 336. (Pubitemid 36169285)
5. Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH (2007). Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 17 : 11 17. (Pubitemid 46452078)
6. Chen HS, Lipton SA (2005). Pharmacological implications of two distinct mechanisms of interaction of memantine with N-Methyl-D-aspartate-gated channels. J Pharmacol Exp Ther 314 : 961 971.
7. Dinse A, Föhr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU (2005). Xenon inhibits AMPA- and kainate-induced membrane currents in cortical neurons. Brit J Anaesth 94 : 479 485. (Pubitemid 40500532)
8. Dorval KM, Wigg KG, Crosbie J, Tannock R, Kennedy JL, Ickowicz A et al 2007). Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav 6 : 444 452. (Pubitemid 47024958)
9. Dresbach T, Hempelmann A, Spilker C, tom Dieck S, Altroch WD, Zuschratter W et al 2003). Functional regions of the presynaptic cytomatrix protein bassoon: significance for synaptic targeting and cytomatrix anchoring. Mol Cell Neurosci 23 : 279 291. (Pubitemid 36703162)
10. Findling RL, Short EJ, McNamara NK, Demeter CA, Stansbrey RJ, Gracious BL et al 2007a). Methylphenidate in the treatment of children and adolescents with bipolar disorder and attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 46 : 1445 1453. (Pubitemid 351338965)
11. Findling RL, McNamara NK, Stansbrey RJ, Maxhimer R, Periclou A, Mann A et al 2007b). A pilot evaluation of the safety, tolerability, pharmacokinetics, and effectiveness of memantine in pediatric patients with attention-deficit/ hyperactivity disorder combined type. J Child Adolesc Psychopharmacol 17 : 19 33. (Pubitemid 46452079)
12. Gilbert DL, Ridel KR, Sallee FR, Zahng J, Lipps TD, Wassermann EM (2006). Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex. Neuropsychopharmacology 31 : 442 449.
13. Goslin K, Banker G (1989). Experimental observations on the development of polarity by hippocampal neurons in culture. J Cell Biol 108 : 1507 1516. (Pubitemid 19097054)
14. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 391 : 85 100. (Pubitemid 11012976)
15. Jensen V, Rinholm JE, Johansen TJ, Medin T, Storm-Mathisen J, Sagvolden T et al 2009). N-methyl-d-aspartate receptor subunit dysfunction at hippocampal glutamatergic synapses in an animal model of attention-deficit/hyperactivity disorder. Neuroscience 158 : 353 364.
16. Kielbasa W, Kalvass JC, Stratford R (2009). Microdialysis evaluation of atomoxetine brain penetration and central nervous system pharmacokinetics in rats. Drug Metab Dispos 37 : 137 142.
17. Kutsuwada T, Kashiwabuchi N, Mori H, Sakimura K, Kushiya E, Araki K et al 1992). Molecular diversity of the NMDA receptor channel. Nature 358 : 36 41.
18. Lou HC (1996). Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy. Acta Paediatr 85 : 1266 1271.
19. Lulé D, Ludolph AC, Ludolph AG (2008). Neurodevelopmental and neurodegenerative diseases - Is there a pathophysiological link? Attention-deficit/hyperactivity disorder and amyotrophic lateral sclerosis as examples. Med Hypotheses 70 : 1133 1138.
20. Michelson D, Read HA, Ruff DD, Witcher J, Zhang S, McCracken J (2007). CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD. J Am Acad Child Adolesc Psychiatry 46 : 242 251. (Pubitemid 46148423)
21. Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS et al the MTA Cooperative Group (2009). The MTA at 8 years: prospective follow-up of children treated for combined type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry 48 : 484 500.
22. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994). Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12 : 529 540. (Pubitemid 24100885)
23. Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M et al 2006). Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study. Am J Psychiatry 163 : 316 318. (Pubitemid 44480854)
24. Moriyoshi K, Masu M, Ishii T, Shigemoto R, Mizuno N, Nakanishi S (1991). Molecular cloning und characterization of the rat NMDA receptor. Nature 354 : 31 37. (Pubitemid 21896774)
25. Pittenger C, Duman RS (2008). Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33 : 88 109.
26. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164 : 942 948. (Pubitemid 46972911)
27. Sauer JM, Ring BJ, Witcher JW (2005). Clinical pharmacokinetics of atomoxetine. Clin Pharmacokinet 44 : 571 590.
28. Scherer D, Hassel D, Bloehs R, Zitron E, von Löwenstern K, Seyler C et al 2009). Selective noradrenaline reuptake inhibitor atomoxetine directly blocks hERG currents. Br J Pharmacol 156 : 226 236.
29. Seneca N, Gulyás B, Varrone A, Schou M, Airaksinen A, Tauscher J et al 2006). Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. Psychopharmacology 188 : 119 127. (Pubitemid 44268248)
30. Sernagor E, Kuhn D, Vyklicky L, Mayer ML (1989). Open channel block of NMDA receptor responses evoked by tricyclic antidepressants. Neuron 2 : 1221 1227.
31. Sobolevsky AI, Yelshansky MV (2000). The trapping block of NMDA receptor channels in acutely isolated rat hippocampal neurons. J Physiol 526 : 493 506. (Pubitemid 30649613)
32. Swanson CJ, Perry KW, Koch-Krueger S, Katner J, Svensson KA, Bymaster FP (2006). Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology 50 : 755 760.
33. Szasz BK, Mike A, Karoly R, Gerevich Z, Illes P, Vizi ES et al 2007). Direct inhibitory effect of fluoxetine on n-methyl-d-aspartate receptors in the central nervous system. Biol Psychiatry 62 : 1303 1309. (Pubitemid 350060896)
34. Szobot CM, Ketzer C, Parente MA, Biederman J, Rohde LA (2004). The acute effect of methylphenidate in Brazilian male children and adolescents with ADHD: a randomized clinical trial. J Atten Disord 8 : 37 43. (Pubitemid 40081858)
35. Witcher JW, Long A, Smith B, Sauer JM, Heilgenstein J, Wilens T et al 2003). Atomoxetine pharmacokinetics in children and adolescents with attention dieficit hyperactivity disorder. J Child Adolesc Psychopharmacol 13 : 53 63. (Pubitemid 36570188)
36. Woodhull AM (1973). Ionic blockage of sodium channels in nerve. J Gen Physiol 61 : 687 708.
37. 2+ and memantine block of rat recombinant NMDA receptors containing chimeric NR2A/2D subunits expressed in Xenopus laevis oocytes. J Physiol 586 : 211 225.